Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03813836
Title Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCC (POPPY)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University College, London
Indications

head and neck squamous cell carcinoma

Therapies

Pembrolizumab

Age Groups: adult | senior
Covered Countries


No variant requirements are available.